Unison Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,957
| Closed | -$81.5K | – | 183 |
|
|
2024
Q2 | $81.5K | Hold |
11,957
| – | – | 0.01% | 180 |
|
|
2024
Q1 | $30.3K | Hold |
11,957
| – | – | ﹤0.01% | 179 |
|
|
2023
Q4 | $28.7K | Hold |
11,957
| – | – | ﹤0.01% | 179 |
|
|
2023
Q3 | $40.7K | Hold |
11,957
| – | – | ﹤0.01% | 180 |
|
|
2023
Q2 | $87.9K | Hold |
11,957
| – | – | 0.01% | 178 |
|
|
2023
Q1 | $124K | Hold |
11,957
| – | – | 0.01% | 177 |
|
|
2022
Q4 | $141K | Hold |
11,957
| – | – | 0.02% | 180 |
|
|
2022
Q3 | $251K | Buy |
11,957
+3,012
| +34% | +$63.2K | 0.05% | 172 |
|
|
2022
Q2 | $278K | Hold |
8,945
| – | – | 0.07% | 158 |
|
|
2022
Q1 | $367K | Buy |
+8,945
| New | +$367K | 0.09% | 138 |
|